Combination of PARP inhibitor olaparib, and PD-L1 inhibitor durvalumab, in recurrent ovarian cancer: a proof-of-concept phase 2 study
Erika J. Lampert, A. Zimmer, M. Padget, A. Cimino-Mathews +14 more
Researcher profile · Semantic Scholar
Erika J. Lampert, A. Zimmer, M. Padget, A. Cimino-Mathews +14 more
Tzu-Ting Huang, Erika J. Lampert, C. Coots, Jung-Min Lee
Erika J. Lampert, Magí Andorrà, R. Torres-Torres, S. Ortiz-Pérez +7 more
E. Martínez-Heras, Federico Varriano, V. Prčkovska, C. Laredo +8 more
Magí Andorrà, Kunio Nakamura, Erika J. Lampert, I. Pulido-Valdeolivas +10 more
E. Martinez-Lapiscina, Elena Fraga‐Pumar, I. Gabilondo, E. Martínez-Heras +11 more
I. Pulido-Valdeolivas, Magí Andorrà, D. Gómez-Andrés, Kunio Nakamura +15 more
Nitasha Gupta, Tzu-Ting Huang, J. Nair, Daniel An +13 more
Erika J. Lampert, A. Cimino-Mathews, J. Lee, J. Nair +6 more
S. Ortiz-Pérez, Magí Andorrà, B. Sánchez-Dalmau, R. Torres-Torres +11 more
Erika J. Lampert, Kingshuk Roy Choudhury, C. Hostage, J. Petrella +1 more
Erika J. Lampert, Kingshuk Roy Choudhury, C. Hostage, Bharath G. Rathakrishnan +3 more
Erika J. Lampert, J. Hays, E. Kohn, C. Annunziata +8 more
Erika J. Lampert, Daniel An, Ann McCoy, E. Kohn +5 more
Nitasha Gupta, Erika J. Lampert, Jung-Min Lee
Erika J. Lampert, Min-Jung Lee, J. Trepel, Akira Yuno +6 more
E. Martinez-Lapiscina, Elena Fraga‐Pumar, I. Gabilondo, E. Martínez-Heras +11 more
Anna Weimer, Erika J. Lampert, S. Tollefson, Zoey Cantor +1 more
Swathi Suresh, Erika J. Lampert, Grace Gorecki, Ian P MacFawn +3 more
I. Valdeolivas, Magí Andorrà, D. Gómez-Andrés, Kunio Nakamura +15 more